These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8510224)

  • 21. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
    Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G
    J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the amino terminus of the hepatitis B virus core antigen within the core particle.
    Karpenko LI; Ryazankin IA; Chikaev NA; Kolesnikova LV; Ilyichev AA
    Virus Res; 1997 Nov; 52(1):15-23. PubMed ID: 9453141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
    Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
    J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.
    Okamoto H; Yotsumoto S; Akahane Y; Yamanaka T; Miyazaki Y; Sugai Y; Tsuda F; Tanaka T; Miyakawa Y; Mayumi M
    J Virol; 1990 Mar; 64(3):1298-303. PubMed ID: 2304145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatitis B virus core gene products with specific immunoreactivity for e antigen (HBeAg) in Saccharomyces cerevisiae.
    Bröker M; Noah M; Nassal M; Dietz S; Ochs J; Bäuml O; Waldinger K; Bodenbenner M; Schott U; Grote M
    J Biotechnol; 1993 Jun; 29(3):243-55. PubMed ID: 7763899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C terminus of the hepatitis B virus e antigen precursor is required for a tunicamycin-sensitive step that promotes efficient secretion of the antigen.
    Messageot F; Carlier D; Rossignol JM
    J Biol Chem; 1998 Jul; 273(29):18594-8. PubMed ID: 9660831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic sites on the arginine-rich carboxyl-terminal domain of the capsid protein of hepatitis B virus distinct from hepatitis B core or e antigen.
    Machida A; Ohnuma H; Takai E; Tsuda F; Tanaka T; Naito M; Munekata E; Miyakawa Y; Mayumi M
    Mol Immunol; 1989 Apr; 26(4):413-21. PubMed ID: 2469950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern.
    Jazayeri SM; Dornan ES; Boner W; Fattovich G; Hadziyannis S; Carman WF
    J Infect Dis; 2004 May; 189(9):1634-45. PubMed ID: 15116300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Venus's-flytrap and cysteine-rich domains of the human Ca2+ receptor are not linked by disulfide bonds.
    Hu J; Reyes-Cruz G; Goldsmith PK; Spiegel AM
    J Biol Chem; 2001 Mar; 276(10):6901-4. PubMed ID: 11238442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
    Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
    J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
    Milich DR; Chen MK; Hughes JL; Jones JE
    J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
    Seifer M; Standring DN
    Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of the immunogenicity of hepatitis B core antigen in a hepatitis B e antigen polypeptide (P19).
    Takahashi K; Imai M; Nomura M; Oinuma A; Machida A; Funatsu G; Miyakawa Y; Mayumi M
    J Gen Virol; 1981 Dec; 57(Pt 2):325-30. PubMed ID: 6172555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.
    Sällberg M; Pushko P; Berzinsh I; Bichko V; Sillekens P; Noah M; Pumpens P; Grens E; Wahren B; Magnius LO
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1335-40. PubMed ID: 7687649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the structure of the terminal regions of the hepatitis B virus gene C polypeptide on the formation of core antigen (HBcAg) particles.
    Khudyakov YuE ; Kalinina TI; Neplyueva VS; Gazina EV; Kadoshnikov YuP ; Bogdanova SL; Smirnov VD
    Biomed Sci; 1991; 2(3):257-65. PubMed ID: 1751758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative immunogenicity of hepatitis B virus core and E antigens.
    Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
    J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-binding activity of hepatitis B e antigen polypeptide lacking the protaminelike sequence of nucleocapsid protein of human hepatitis B virus.
    Matsuda K; Satoh S; Ohori H
    J Virol; 1988 Sep; 62(9):3517-21. PubMed ID: 3404582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.